Analabs Resources Bhd (7083) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Analabs Resources Bhd stock MYR 2.17, price MYR 1.74, upside +24.7%, quality 58 out of 100. Rating: undervalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range 0.7516 MYR – 1.85 MYR · fair‑value band 1.84 MYR – 2.40 MYR · the 1.74 MYR price screens below the 2.17 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.
Follow Analabs Resources Bhd in your weekly email
Every Wednesday you see whether Analabs Resources Bhd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Analabs Resources Berhad, an investment holding company, manufactures, formulates, and sells resins, chemicals, and building materials in Malaysia, rest of Asia, and internationally.
Show moreShow less
The company operates through six segments: Asset and Portfolio Management; Manufacturing, Formulation and Sale of Resin, Chemicals and Building Materials; Contract Work, Pipe Laying and Rehabilitation; Investment Holding and Property Letting; Recovery and Sale of Recycled Products; and Culture and Sale of Prawns.
It also collects, treats, recovers, and recycles industrial and organic waste, as well as sells recycled products.
In addition, the company engages in breeding and selling of prawns; and manufacturing and trading of lubricant products and resin impregnated papers, as well as asset and portfolio management.
Further, it operates as a general contractor of water and sewer diversion construction and maintenance, and labour supply for sewer and water rehabilitation construction; offers management and property letting services; manages investment portfolios; and trades in, imports, and distributes ceramic tiles and building materials.
The company was founded in 1936 and is based in Petaling Jaya, Malaysia.
Stock analysis
Analabs Resources Bhd (7083) currently trades at 1.74 MYR, while our model-based Fair Value estimate is 2.17 MYR, implying the stock looks roughly 20% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 6.94 MYR per share, and 20 of the 23 models we run sit above the 1.74 MYR price.
Bear case: the Dividend Discount group reads lowest at 0.3950 MYR, and 3 of the 23 models stay below the price. Data coverage for this calculation is low.
Scenario range: 1.84 MYR (bear) to 2.40 MYR (bull), the price of 1.74 MYR sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 58/100 (solid quality), in the Basic Materials sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
Analabs Resources Bhd reported revenue of 128M MYR in FY2026 versus 118M MYR in FY2022, a compound +2.1%/yr. Reported net income was 48.9M MYR in FY2026, compounding +13.5%/yr from FY2022.
Key figures
Market cap 193M MYR (≈ $47.6M) Micro · P/E ratio 3.9 · P/S ratio 1.41 · EPS (TTM) 0.4500 MYR · Dividend yield 2.3% · Net margin 36.1% · Return on equity 9.8% · Return on assets (EBIT) 7.0% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 60 out of 100 (low confidence).
What moves the price
The share trades about 5% below its 52-week high and 7% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at 25%, 7083 screens cheaper than that median.
Fair Value models
Bear1.84 MYRFair Value 2.17 MYRBull2.40 MYR
Price 1.74 MYR · Upside +24.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (0.2379 MYR per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF6.59 MYR8.88 MYR12.93 MYR81
Growth DCF6.85 MYR9.05 MYR12.65 MYR79
Owner Earnings5.86 MYR7.89 MYR11.48 MYR77
All 24 models by family
DCF Models
FCF DCF6.59 MYR8.88 MYR12.93 MYR81
Owner Earnings5.86 MYR7.89 MYR11.48 MYR77
5Y Revenue Exit3.45 MYR4.11 MYR5.05 MYR74
5Y EBITDA Exit4.47 MYR5.87 MYR7.74 MYR76
5Y P/E Exit5.67 MYR7.94 MYR10.68 MYR71
10Y Revenue Exit4.66 MYR5.26 MYR5.82 MYR68
10Y EBITDA Exit5.30 MYR6.32 MYR7.35 MYR70
10Y P/E Exit6.00 MYR7.56 MYR9.03 MYR65
Earnings-Based
Graham-Dodd3.01 MYR3.68 MYR4.13 MYR67
EPV3.50 MYR4.01 MYR4.45 MYR74
Dividend Discount
Gordon GGM0.3400 MYR0.3700 MYR0.4200 MYR69
DDM Multi-Stage0.3400 MYR0.4200 MYR0.5300 MYR67
Multiples
P/E Multiple5.64 MYR7.52 MYR9.40 MYR63
P/S Multiple1.30 MYR1.73 MYR2.16 MYR58
P/B Multiple11.70 MYR15.60 MYR19.50 MYR55
EV/EBIT2.30 MYR3.73 MYR5.15 MYR64
EV/EBITDA1.31 MYR2.41 MYR3.51 MYR65
EV/Revenuen/an/a0.2600 MYR50
Asset-Based
NCAV (Graham)2.60 MYR3.48 MYR5.20 MYR54
Growth DCF
Growth DCF6.85 MYR9.05 MYR12.65 MYR79
Rev-Margin DCF3.43 MYR4.09 MYR4.90 MYR74
Economic Profit
Residual Income4.41 MYR4.75 MYR5.25 MYR76
ROIC Compounder3.50 MYR4.01 MYR4.45 MYR72
Growth Earnings
Growth-Adj P/E4.02 MYR5.74 MYR7.46 MYR67
The fair value above starts from this blend and is adjusted for a cyclical peak year.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
−7.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.7%
Start year 2021 (pandemic). Over 10 years: −1.9% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.1%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in MYR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in MYR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
≈ +18.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+15.7%
Dividend (yield on the price)2.3%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.24.0% vs 16.1%, picking up
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.18% → 35%
Pace: the 5-year rate starts in 2021 (pandemic)
⚠ Rate on operating basis: 2026 sits 74% above its own trend.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−9.6%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Malaysia: IMF forecast 2.0% a year to 2030, 1.8% from 2016 to 2025) that is about −11.3% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 728 stocks
Beats the industry median on 13/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score58 · Above median
Fair Value upside+24.7% · Top 25%
Profitability
Return on equity (12 months)9.8% · Above median
Return on assets5.5% · Above median
Net margin (12 months)36.1% · Top 25%
Operating margin (12 months)16.8% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)14.6% · Above median
Dividend yield (12 months)2.3% · Above median
Balance sheet
Debt / equity0.01× · Below median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Analabs Resources Bhd Fair Value". https://www.fairvalue-calculator.com/stock/7083
Frequently asked questions
Is Analabs Resources Bhd (7083) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of 2.17 MYR versus a price of 1.74 MYR, about +25% upside (undervalued).
What is the fair value of 7083?
Our model-based fair value for Analabs Resources Bhd is 2.17 MYR (as of Nov 7, 2026), built from audited fundamentals. The current price: 1.74 MYR.
What is the quality score of 7083?
Analabs Resources Bhd has a Quality Score of 58/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Analabs Resources Bhd (7083)?
Our model-based price target is the fair value of 2.17 MYR (as of Nov 7, 2026) from 24 valuation models. Cautious scenario 1.84 MYR, optimistic scenario 2.40 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the Analabs Resources Bhd stock forecast for 2026?
Our models put fair value at 2.17 MYR, about +25% upside versus a price of 1.74 MYR (undervalued). Cautious scenario 1.84 MYR, optimistic scenario 2.40 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Analabs Resources Bhd (7083)?
Analabs Resources Bhd reported trailing-twelve-month revenue of about 137M MYR (latest available figure, as of Nov 7, 2026).
Does Analabs Resources Bhd pay a dividend?
Analabs Resources Bhd currently shows a dividend yield of 2.28% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of Analabs Resources Bhd (7083)?
Analabs Resources Bhd has a dividend yield of 2.3%.
What growth is priced into Analabs Resources Bhd (7083)?
For today's price to be fair in a discounted-cash-flow model, Analabs Resources Bhd would have to grow free cash flow by -9.6 % per year for five years (discount rate 9.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +1.7 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of 7083 use?
Our models discount Analabs Resources Bhd at 9.7 %: a base by market capitalisation (nano), damped by beta 0.30, country premium for Malaysia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Analabs Resources Bhd that is -9.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.7 %) and the same formula as our fair value.
How much growth has Analabs Resources Bhd (7083) delivered so far?
Over the past 5 years revenue at Analabs Resources Bhd grew +1.7 % a year. The price currently implies free-cash-flow growth of -9.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Analabs Resources Bhd (7083) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into Analabs Resources Bhd (-9.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Analabs Resources Bhd (7083)?
The free-cash-flow yield on the price is 30.76 %: that much free cash flow Analabs Resources Bhd produces per unit of market value. When it exceeds the discount rate of our models (9.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Analabs Resources Bhd (7083)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Analabs Resources Bhd it is 2.17 MYR per share (as of Nov 7, 2026), against a price of 1.74 MYR. It is the blended result of 24 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Analabs Resources Bhd stock overvalued or undervalued in 2026?
As of Nov 7, 2026, 7083 trades below its calculated fair value: price 1.74 MYR, fair value 2.17 MYR, a gap of about +25% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 7083?
No. The price is what the market pays today (1.74 MYR); the fair value is what the company's own numbers justify (2.17 MYR). For Analabs Resources Bhd the two are 0.4297 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Analabs Resources Bhd worth?
The market values Analabs Resources Bhd at about 193M MYR (market capitalisation, as of Nov 7, 2026). Per share that is 1.74 MYR; our models calculate a fair value of 2.17 MYR per share.
What do the bullish and bearish scenarios say about 7083?
Our models span a range for Analabs Resources Bhd: cautious scenario 1.84 MYR, base 2.17 MYR, optimistic 2.40 MYR per share (as of Nov 7, 2026, price 1.74 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 7083?
Analabs Resources Bhd trades at a price-to-earnings ratio of 3.9 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 2.17 MYR is built from several models across several years. Other multiples: P/B 0.3, P/S 1.4, EV/EBITDA 2.6.
How solid is the balance sheet of Analabs Resources Bhd (7083)?
Balance-sheet figures for Analabs Resources Bhd (as of Nov 7, 2026): return on equity 9.8%, debt of 0.01 per unit of equity. They feed the Quality Score of 58/100, which measures business quality independently of the share price.
How far is 7083 from its 52-week high?
Analabs Resources Bhd trades at 1.74 MYR, about 5% below its 52-week high of 1.83 MYR and 7% above the low of 1.62 MYR (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 2.17 MYR is for.
Which stocks are comparable to Analabs Resources Bhd?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Analabs Resources Bhd stock attractive at the current price?
The data as of Nov 7, 2026: price 1.74 MYR, calculated fair value 2.17 MYR (+25%), Quality Score 58/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 7083 calculated?
We run Analabs Resources Bhd through 24 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 2.17 MYR builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Analabs Resources Bhd currently trades 20% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Analabs Resources Bhd (7083)?
The closing price on Nov 6, 2026 was 1.74 MYR. Our model-based fair value is 2.17 MYR, about +25% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Analabs Resources Bhd right now?
The price is below even our cautious bear case (1.84 MYR). The market is more pessimistic than our downside scenario. Solid quality (58/100) at a price below fair value, the discount is the argument here, not the business quality. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Analabs Resources Bhd
How large is the market capitalisation of Analabs Resources Bhd (7083)?
The market capitalisation of Analabs Resources Bhd is 193M MYR (≈ $47.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Analabs Resources Bhd (7083)?
The price-to-sales ratio of Analabs Resources Bhd is 1.41 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Analabs Resources Bhd (7083)?
Earnings per share at Analabs Resources Bhd are 0.4500 MYR (price ÷ EPS = P/E 3.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Analabs Resources Bhd (7083)?
The dividend yield of Analabs Resources Bhd is 2.3% (payout 8.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Analabs Resources Bhd (7083)?
The net margin of Analabs Resources Bhd is 36.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Analabs Resources Bhd (7083)?
The return on equity (ROE) of Analabs Resources Bhd is 9.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Analabs Resources Bhd (7083)?
On an EBIT basis the return on assets of Analabs Resources Bhd is 7.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Analabs Resources Bhd (7083)?
The operating margin of Analabs Resources Bhd is 16.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Analabs Resources Bhd (7083)?
Revenue at Analabs Resources Bhd is growing +14.6% versus a year earlier (3y avg −1.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Analabs Resources Bhd (7083)?
Earnings per share at Analabs Resources Bhd are growing +114% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Analabs Resources Bhd (7083) carry?
The net debt of Analabs Resources Bhd is 220M MYR (fiscal year 2026, ≈ 3.7 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Analabs Resources Bhd in the live analysis
One click puts Analabs Resources Bhd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 7, 2026